HYDROXYSTILBAMIDINE ISETHIONATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydroxystilbamidine Isethionate, and what generic alternatives are available?
Hydroxystilbamidine Isethionate is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in HYDROXYSTILBAMIDINE ISETHIONATE is hydroxystilbamidine isethionate. Additional details are available on the hydroxystilbamidine isethionate profile page.
Summary for HYDROXYSTILBAMIDINE ISETHIONATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 11 |
Patent Applications: | 39 |
DailyMed Link: | HYDROXYSTILBAMIDINE ISETHIONATE at DailyMed |
US Patents and Regulatory Information for HYDROXYSTILBAMIDINE ISETHIONATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | HYDROXYSTILBAMIDINE ISETHIONATE | hydroxystilbamidine isethionate | INJECTABLE;INJECTION | 009166-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |